MedPath

Patient Self-sampling of HPV to Screen for Cervical Cancer

Not Applicable
Completed
Conditions
Human Papilloma Virus
Registration Number
NCT05600283
Lead Sponsor
Mayo Clinic
Brief Summary

The purpose of this study is to validate a patient self-sampling vaginal collection kit and laboratory testing for the detection of HPV (human papillomavirus) infection. Researchers will compare the laboratory results of self-collected vaginal swab samples to usual healthcare provider-collected cervical swab samples to determine the laboratory HPV testing accuracy of the self-collection swab.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
225
Inclusion Criteria
  • Appointment at Mayo Clinic Rochester in Gynecology Colposcopy Clinic or ICS (integrated community specialty) Colposcopy Clinic (will always include a speculum exam).
  • Appointment at Mayo Clinic Rochester in Gynecology Clinic for indication that will already include a speculum exam (e.g., cervical cancer screening or IUD insertion).
Exclusion Criteria
  • Excluded if self-reported as currently menstruating, pregnant, or within 3 months following pregnancy.
  • Excluded if no cervix (history of total hysterectomy).
  • Excluded if moderate to heavy vaginal bleeding on the day of the visit.
  • Excluded if reason for visit in Gynecology Clinic is abnormal vaginal discharge.
  • Exclude patients who are on Gynecology Colposcopy Clinic for LEEP (loop electrosurgical excision procedure).
  • Exclude if any use of over-the-counter or prescription vaginal cream for vaginal infection or prescription vaginal estrogen cream for at least two days before using the Evalyn Brush.

(Vaginal contraceptives, condoms and water-based lubricants can be used as normal.)

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Concordance of Patient-collected and Clinician-collected Samples to Detect HPV InfectionBaseline (sample was collected up to 21 days form the date of registration)

Patient-collected vaginal swab HPV results compared with gold standard of clinician-collected cervical swab) to accurately detect HPV infection

Secondary Outcome Measures
NameTimeMethod
Patient-reported Acceptability of Using the Evalyn BrushBaseline (sample was collected up to 21 days form the date of registration)

Assessed by survey question "Overall, how acceptable was it for you to collect the sample using the Evalyn® brush?," which was answered on a 4-point scale (completely unacceptable, unacceptable, acceptable, or completely acceptable).

Trial Locations

Locations (1)

Mayo Clinic Minnesota

🇺🇸

Rochester, Minnesota, United States

Mayo Clinic Minnesota
🇺🇸Rochester, Minnesota, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.